Analysis of Eicosanoids in Blood Using the Same Sample Preparation Method as for Primary Metabolite Analysis

Significance of the Topic

Eicosanoids are bioactive lipids involved in key physiological processes such as inflammation and blood coagulation and are important targets for biomarker discovery.

Objectives and Study Overview

This study aims to quantify seven eicosanoids in blood samples using gas chromatography–mass spectrometry (GC-MS) with derivatization, employing the same sample preparation protocol as for primary metabolite analysis.

Methodology and Instrumentation

Sample Preparation

• Deproteinization of plasma with methanol/water/chloroform followed by centrifugal drying.
• Methoximation of ketone groups with methoxyamine hydrochloride at 30 °C for 90 minutes.
• Trimethylsilylation using MSTFA at 37 °C for 30 minutes to enhance volatility and chromatographic separation.

Instrumentation

• GC-MS system: GCMS-TQ8050 NX with a DB-5MS column (30 m × 0.25 mm, 0.25 μm).
• GC conditions: splitless injection, helium carrier gas at 40 cm/s, temperature program from 150 °C to 300 °C.
• MS conditions: electron ionization, multiple reaction monitoring with optimized transitions for each derivatized eicosanoid.

Key Results and Discussion

Calibration curves exhibited second-order behavior with R2 ≥ 0.995. The method achieved high sensitivity, detecting around 10 ng/mL with an S/N ratio of 53 for challenging analytes like thromboxane B2. Recoveries in spiked plasma ranged from 80.4 to 119.3 percent, demonstrating robustness across the seven compounds. Isomeric prostaglandins such as PGE2 and 11β-PGE2 were effectively separated.

Benefits and Practical Applications

• Single sample preparation allows simultaneous analysis of primary metabolites and eicosanoids.
• Enhanced peak shapes and sensitivity for analytes that are difficult to analyze by LC-MS.
• Applicable to blood samples with low analyte concentrations of approximately 10 ng/mL.

Future Trends and Opportunities

Integration with metabolomics databases and multivariate analysis platforms such as Garuda may enable comprehensive metabolic profiling. Further development of automated derivatization protocols and more stable derivative chemistries could extend application to larger biomarker studies.

Conclusion

The described GC-MS method with methoximation and trimethylsilylation provides a sensitive and reliable approach to quantifying seven key eicosanoids in blood using a unified sample preparation workflow.